Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

By Chujoh Y.   Matsuo K.   Yoshizaki H.   Nakasatomi T.   Someya K.   Okamoto Y.   Naganawa S.   Haga S.   Yoshikura H.   Yamazaki A.   Yamazaki S.   Honda M.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 797-804

Elsevier

Access to resources Recommend Favorite

Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums

By Aldwell F.E.   Keen D.L.   Parlane N.A.   Skinner M.A.   de Lisle G.W.   Buddle B.M.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 70-76

Elsevier

Access to resources Recommend Favorite

Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG

By Buddle B.M.   de Lisle G.W.   Pfeffer A.   Aldwell F.E.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1123-1130

Elsevier

Access to resources Recommend Favorite

UV-Induced Inactivation Rates for Airborne Mycobacterium bovis BCG

By Peccia Jordan   Hernandez Mark  

Journal of Occupational and Environmental Hygiene, Vol. 1, Iss. 7, 2004-07 ,pp. : 430-435

Taylor & Francis Ltd

Access to resources Recommend Favorite

Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen

By Kawahara M.   Matsuo K.   Nakasone T.   Hiroi T.   Kiyono H.   Matsumoto S.   Yamada T.   Yamamoto N.   Honda M.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 158-166

Elsevier

Access to resources Recommend Favorite